Clinical Trial Update: The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary Calcium [Phase 2, Phase 3]

View source ↗

Summary

Brigham and Women's Hospital's Phase 2/3 trial investigating the effect of vitamin D on urinary calcium excretion in kidney stone formers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Vitamin D Deficiency, Nephrolithiasis | Phase 2, Phase 3 | Status: WITHDRAWN